Image by freepikGene therapyPurespring bags £80m to transform kidney...Purespring Therapeutics, a pioneering gene therapy company focused on transforming kidney disease treatment, has raised £80 (€96m) in an oversubscribed Series B round. Led by Sofinnova Partners, this … more ➔
World Health SummitWHS 2024WHO: One billion US$ for global healthA total of US$1bn was pledged to the WHO at this year’s World Health Summit in Berlin for the fight against Mpox, Marburg virus and the consequences of climate change. more ➔
Ikerian AGAISwiss Ikerian AG partner with Sanoptis Inc...Swiss Ikerian AG’s US-subsidiary, RetinAI U.S. Inc. has announced the first close of an CHF6.73m Series B financing with new and existing investors to advance its AI-based image analysis platform alongside … more ➔
Molcure IncPartnershipAntibody developer Yumab partners with Jap...German antibody specialist YUMAB GmbH has inked a collaboration agreement with Japanese MOLCURE Inc aimed at using the company’s zero-shot AI technology for antibody discovery. more ➔
Stijnstijl fotografieVCForbion raises more than €2bn for two ne...Dutch Forbion has announced its largest fundraising to date, with Forbion’s Growth Opportunities Fund III raising €1.2bn and Forbion Ventures Fund VII raising €890m. more ➔
H.Lundbeck A/SM&ALundbeck to take over Longboard Pharma in...Lundbeck A/S is set to take over all shares of neurology specialist Longboard Pharmaceuticals Inc worth US$2.6bn to strengthen its pipeline with the Phase III 5-hydroxythyprytamaine 2C receptor super-agonist … more ➔
Sphingotec GmbHPartnershipSphingotec licenses kidney function testGerman diagnostics company Sphingotec GmbH has licensed its real-time kidney function test to US diagnostics giant Beckman Coulter allowing it to expand its business to the US as announced earlier this … more ➔
Astellas Pharma IncLicence dealAviadoBio Ltd inks US$2.2bn gene therapy d...AviadoBio Ltd has cashed in €30m upfront and €20m as an equity investment from Astellas Pharma Inc for signing a licence option agreement for its Phase I/II gene therapy programme AVR-01. more ➔
AI via FreepikFinancingVicore secures funding to accelerate drug...Swedish clinical-stage pharmaceutical company Vicore Pharma has secured SEK100m, supported by existing and new investors. The injection of capital will allow the company to scale the clinical development … more ➔
EIBFinancing€20m loan for pandemic preparednessFab’entech, a French biopharma company, has secured a loan worth €20m from the European Investment Bank (EIB) under the HERA Invest programme, aimed at bolstering Europe’s preparedness against biological … more ➔
Image by freepik
World Health Summit
Ikerian AG
Molcure Inc
Stijnstijl fotografie
H.Lundbeck A/S
Sphingotec GmbH
Astellas Pharma Inc
AI via Freepik
EIB